|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
S37.13XA |
Laceration of ureter, initial encounter
|
S3713XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 12 |
ICD10
Position 23 |
| 31.82%
|
27.27%
|
13.64%
|
4.55%
|
9.09%
|
4.55%
|
4.55%
|
4.55%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for S37.13XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
87150
|
DNA/RNA AMPLIFIED PROBE |
27
|
27
|
|
C1769
|
GUIDE WIRE |
6
|
10
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
5
|
40
|
|
J2405
|
ONDANSETRON HCL INJECTION |
5
|
20
|
|
J3010
|
FENTANYL CITRATE INJECTION |
5
|
10
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
5
|
5
|
|
80048
|
METABOLIC PANEL TOTAL CA |
5
|
5
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
5
|
20
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
4
|
110
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
3
|
28
|
|
50431
|
NJX PX NFROSGRM &/URTRGRM |
3
|
3
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
3
|
170
|
|
C1758
|
CATHETER, URETERAL |
3
|
3
|
|
52310
|
CYSTOSCOPY AND TREATMENT |
2
|
2
|
|
87040
|
BLOOD CULTURE FOR BACTERIA |
2
|
2
|
|
82962
|
GLUCOSE BLOOD TEST |
2
|
2
|
|
87635
|
SARS-COV-2 COVID-19 AMP PRB |
2
|
2
|
|
C2617
|
STENT, NON-COR, TEM W/O DEL |
2
|
2
|
|
J2001
|
LIDOCAINE INJECTION |
2
|
18
|
|
50947
|
LAPARO NEW URETER/BLADDER |
2
|
2
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
S37.13XA related to the following DRG Codes:
698-700
963-965
|
